Telix Pharmaceuticals (TLX1N.MX) Q1 2026 Earnings

19FebConfirmed
Q1 2025
Q3 2025
Q1 2026
-0.2
0.7
1.6
2.5

Details

Expected EPS
0.5649063567
Actual EPS
-0.19998516
Surprise EPS
-0.76
Surprise Percent
+135.4%

Description

Telix Pharmaceuticals (TLX1N.MX) has reported earnings of -0.19998516 per share for Q1 2026.

0 Comments

Share your thoughts